A pilot safety study of ublituximab, a monoclonal antibody against CD20, in acute relapses of neuromyelitis optica spectrum disorder

Mealy, MA; Levy, M

Levy, M (reprint author), Massachusetts Gen Hosp, Dept Neurol, 15 Parkman St, Boston, MA 02114 USA.; Levy, M (reprint author), Harvard Med Sch, 15 Parkman St, Boston, MA 02114 USA.

MEDICINE, 2019; 98 (25):

Abstract

Objective: To test the safety of ublituximab, a B cell depleting agent, as add-on therapy in the acute treatment of relapses of neuromyelitis optica s......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索